ANB033

N/A

Report date: 2022/12/01 17:18:45

Base Information

Drug NameANB033
Drug Alias NameANB-033
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-2 receptor beta chain antagonists
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnaptysbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnaptysbio Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A